Clinical trials: Hypomagnesemia
Hypomagnesemia in Type 2 Diabetic Patients
MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus
To determine the effect of MLD10 (magnesium L-lactate dihydrate extended-release caplets) 10 mEq BID on serum magnesium in Type 2 diabetic patients with hypomagnesemia.
- Trial name
- NCT03567824
- Testing
- Magnesium L-lactate dihydrate
- Volunteers
- 200 people
- Sponsor
- Pharmalyte Solutions LLC